NSETrading Window24 Jun 2026 · 24 Jun 2026, 03:01 pm

Trading Window

Lincoln Pharmaceuticals Limited · LINCOLN

✦ AI Summary

Lincoln Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Lincoln Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

LINCOLN_24062026150048_Intimation.pdf

pdf

Download →
View document text
LINCOLN PHARMACEUTICALS L TO. HlaAL TH CARE FOR ALL Date: June 24, 2026 To, To, The Manager, Listing Department, The Department of Corporate Service, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C – 1, Block – G, 1st Floor, New Trading Ring, Bandra – Kurla Complex, Bandra (E), Rotunda Building, Phiroze Jeejeebhoy Tower, Mumbai-400 051. Dalal Street, Mumbai – 400 001. Scrip Code – LINCOLN Scrip Code – 531633 Dear Sir/Madam, Sub: Intimation of Closure of Trading Window We would like to inform that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and amendment thereto ("Regulations") and Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information adopted by the Company, the Trading Window for dealing in the securities of the Company shall remain closed from July 01, 2026 till 48 hours after the declaration of the unaudited Financial Results of the Company, for the quarter ended June 30, 2026. The date of meeting of the Board of Directors, to approve the unaudited Financial Results of the Company for the quarter ended June 30, 2026, will be informed in due course. Accordingly, all Directors, Senior Management Personnel, Promoter and Promoter Group of the Company and its subsidiaries including their Immediate Relatives and other Connected Persons are advised not to trade in securities of the Company during the aforesaid period of closure of trading window. We request you to kindly take the same on record. Thanking you, Yours faithfully, FOR LINCOLN PHARMACEUTICALS LTD TRUSHA K. SHAH COMPANY SECRETARY & COMPLIANCE OFFICER Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India • Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com I Website: www.lincolnpharma.com Factory: 10, 12, 13. Trimul Estate. Near Khatraj Chokadi, P.O. Khatraj-382721. lntertek • •• Ta.: Kalal, Dist. Gandhinagar, (Guj.) I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com